Cardiome To Slash Workforce by 85% on End of Merck's Oral Development Program

Date : 07/09/2012 @ 10:34AM
Source : Dow Jones News
Stock : Merck & Company (New) (MRK)
Quote : 62.7  0.0 (0.00%) @ 4:57AM

Cardiome To Slash Workforce by 85% on End of Merck's Oral Development Program

Cardiome (NASDAQ:CRME)
Historical Stock Chart

5 Years : From Apr 2012 to Apr 2017

Click Here for more Cardiome Charts.
   By Chelsea Stevenson 
 

Cardiome Pharma Corp. (CRME) plans to reduce its workforce by about 85% in response to the termination of Merck & Co.'s (MRK) developing vernakalant oral program.

All positions focused on internal research and certain supporting functions will be eliminated, Canadian-based Cardiome Pharma said. The reductions will result in up to $5 million in severance charges over the remainder of the year.

In March, Cardiome's partner Merck discontinued its development of its oral vernakalant drug, which prevented atrial fibrillation. Cardiome had said it was disappointed with Merck's decision.

Interim Chief Executive Dr. William Hunter said the board regrets the effects of the decision. Dr. Hunter replaced former Chief Executive Doug Janzen, who left the company last week.

Cardiome Pharma reported a slightly narrower loss for its first quarter, citing clinical development efforts and pre-clinical research project expenditures. The latest quarter's loss also includes employee termination charges.

The company said it will issue a further progress report in mid-August to its shareholders.

Shares were off 2.3% to 43 cents in recent trading and have dropped 84% this year.

Write to Chelsea Stevenson at chelsea.stevenson@dowjones.com




Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.